Structures by: Rakovský E.
Total: 16
(E,E)-2,6-Bis{2-[4-(N,N-diphenylamino)phenyl]ethenyl}benzo[1,2-d:4,5-d'] bisthiazole
C48H34N4S2,2(CHCl3)
Organic letters (2014) 16, 24 6358-6361
a=9.7874(5)Å b=11.8977(6)Å c=22.0108(11)Å
α=101.686(4)° β=91.082(4)° γ=107.507(5)°
1,4-butanediamminium dihydrogendecavanadate
H2O28V10,2(C4H14N2)
Acta Crystallographica Section E (2006) 62, 8 m1820-m1822
a=10.22680(10)Å b=16.7196(2)Å c=18.2311(2)Å
α=90.00° β=90.00° γ=90.00°
Butane-1,4-diammonium decavanadate(V) hexahydrate
3C4H14N22,V10O286,6H2O
Acta Crystallographica Section E (2006) 62, 9 m2108-m2110
a=10.6504(4)Å b=17.6351(4)Å c=10.9644(4)Å
α=90.00° β=92.0375(16)° γ=90.00°
1-H-nicotinamidium(1+) decavanadate(V) dihydrate
6(C6H7N2O),V10O286,2(H2O)
Acta Crystallographica Section C (2007) 63, 9 m419-m422
a=25.806(9)Å b=9.5460(13)Å c=23.577(10)Å
α=90.00° β=106.60(4)° γ=90.00°
Bis[2-(2-hydroxyethyl)pyridinium] μ-decavanadato-bis[pentaaquamanganate(II)] tetrahydrate
2(C7H10NO),V10Mn2H20O38,4(H2O)
Acta Crystallographica Section C (2009) 65, 2 m97-m99
a=9.58016(9)Å b=11.33329(13)Å c=12.07540(17)Å
α=78.3429(11)° β=74.6559(11)° γ=66.0748(10)°
2,6-Lutidinium dihydrogendecavanadate dihydrate
4(C7H10N),H2V10O284,2(H2O)
Acta Crystallographica Section E (2014) 70, 6 m225-m226
a=24.7777(5)Å b=8.35654(16)Å c=25.0089(6)Å
α=90° β=113.878(3)° γ=90°
<i>catena</i>-Poly[[(pyrazine-2-carboxamide-κ<i>N</i>^4^)copper(I)]-μ~3~-iodido]
C5H5Cu1I1N3O1
Acta Crystallographica Section E (2014) 70, 7 m267-m268
a=29.5408(7)Å b=4.07950(10)Å c=14.3164(3)Å
α=90° β=111.712(3)° γ=90°
(R,Rp)-N,N-dimethyl-1-(2-phenylferrocenyl)ethan-1-amine - phenol (1/1)
C20H23FeN,C6H6O
The Journal of organic chemistry (2019) 84, 11 7312-7319
a=9.02944(9)Å b=10.3803(2)Å c=23.2249(2)Å
α=90° β=90° γ=90°
2-((3R*,3'R*,4'S*,5'R*)-1-benzyl-3'-(4-methoxyphenyl)-2-oxo-5'- phenylspiro[indoline-3,2'-pyrrolidin]-4'-yl)-N-methyl-2-oxoacetamide
C34H31N3O4
To be published
a=13.7836(7)Å b=16.0469(6)Å c=13.3142(6)Å
α=90° β=104.034(4)° γ=90°
(3R*,3'R*)-1-benzyl-3'-(4-methoxyphenyl)-N,N-dimethyl-2-oxo-3',4'- dihydrospiro[indoline-3,2'-pyrrole]-5'-carboxamide
C28H27N3O3
To be published
a=8.9767(4)Å b=10.3314(4)Å c=14.0050(6)Å
α=72.503(3)° β=80.490(3)° γ=66.171(3)°
2-((3R*,3'S*,4'R*,5'S*)-1-benzyl-3'-(4-methoxyphenyl)-2-oxo-5'- phenylspiro[indoline-3,2'-pyrrolidin]-4'-yl)-N,N-dimethyl-2-oxoacetamide
C35H33N3O4
To be published
a=12.6070(7)Å b=10.0698(6)Å c=24.0356(16)Å
α=90° β=103.397(5)° γ=90°
Ethyl-2-((3S*,3'S*,4'R*,5'S*)-1-benzyl-3'-(4-methoxyphenyl)-2-oxo- 5'-phenylspiro[indoline-3,2'-pyrrolidin]-4'-yl)-2-oxoacetate ethanol solvate
C37H38N2O6
To be published
a=7.9603(3)Å b=13.4478(6)Å c=28.8213(12)Å
α=90° β=93.274(3)° γ=90°
4,7-bis[4-(N,N-diphenylamino)phenylethynyl]benzothiazole
C48H32Cl3N3S
To be published
a=10.5498(8)Å b=14.4285(11)Å c=15.594(2)Å
α=114.536(7)° β=99.447(8)° γ=101.858(6)°
6,6'-bis(N,N-dimethylamino)-2,2'-bibenzothiazole
C18H18N4S2
To be published
a=7.6141(5)Å b=7.7816(5)Å c=8.7101(5)Å
α=65.948(4)° β=68.659(5)° γ=62.896(4)°
4,7-diiodo-2-methylbenzothiazole
C8H5I2NS
To be published
a=13.1690(6)Å b=4.2536(3)Å c=19.0445(9)Å
α=90° β=102.592(4)° γ=90°
Tert-butyl ((S)-1-benzyl-5-bromo-3-((R)-4-fluoro-3-methyl-5-oxo-1-phenyl- -4,5-dihydro-1H-pyrazol-4-yl)-2-oxoindolin-3-yl)carbamate
C30H28BrFN4O4
To be published in other ACS journals
a=9.47750(10)Å b=11.6057(2)Å c=12.6312(2)Å
α=90° β=91.7070(10)° γ=90°